Cargando…

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma

Sonic hedgehog (SHH) medulloblastoma (MB) subtype is driven by a proliferative CD15+ tumor propagating cell (TPC), also considered in the literature as a putative cancer stem cell (CSC). Despite considerable research, much of the biology of this TPC remains unknown. We report evidence that phosphata...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Alok R., Joshi, Shweta, Zulcic, Muamera, Alcaraz, Michael, Garlich, Joseph R., Morales, Guillermo A., Cho, Yoon J., Bao, Lei, Levy, Michael L., Newbury, Robert, Malicki, Denise, Messer, Karen, Crawford, John, Durden, Donald L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777592/ https://www.ncbi.nlm.nih.gov/pubmed/26938241 http://dx.doi.org/10.1371/journal.pone.0150836

Ejemplares similares

A PKC-SHP1 signaling axis desensitizes Fcγ receptor signaling by reducing the tyrosine phosphorylation of CBL and regulates FcγR mediated phagocytosis
por: Joshi, Shweta, et al.
Publicado: (2014)

Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo
por: Joshi, Shweta, et al.
Publicado: (2014)

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype
por: Joshi, Shweta, et al.
Publicado: (2017)

The transcriptional landscape of Shh medulloblastoma
por: Skowron, Patryk, et al.
Publicado: (2021)

Evasion of cell senescence in SHH medulloblastoma
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2016)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019)

Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
por: Caimano, Miriam, et al.
Publicado: (2021)

Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma
por: Neve, Anuja, et al.
Publicado: (2019)

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
por: Ghasemi, David R., et al.
Publicado: (2022)

Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors
por: Moss, Rachel M., et al.
Publicado: (2023)

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
por: Lee, Chanhee, et al.
Publicado: (2018)

Disruption of rack1 suppresses SHH‐type medulloblastoma formation in mice
por: Liu, Fengjiao, et al.
Publicado: (2021)

BIOL-08. IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA
por: Kunhiraman, Haritha, et al.
Publicado: (2021)

EMBR-19. SHH-DRIVEN MEDULLOBLASTOMA WITH CONCURRENT UNILATERAL RENAL AGENESIS
por: Aaroe, Ashley, et al.
Publicado: (2021)

Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression
por: Wynn, Daniel T, et al.
Publicado: (2022)

Biallelic loss of GNAS in a patient with pediatric medulloblastoma
por: Tokita, Mari J., et al.
Publicado: (2019)

Medulloblastoma with Excessive Nodularity: Radiographic Features and Pathologic Correlate
por: Yeh-Nayre, L. A., et al.
Publicado: (2012)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2021)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2023)

Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma
por: Łastowska, Maria, et al.
Publicado: (2019)

Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma
por: Azzollini, Jacopo, et al.
Publicado: (2020)

Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2019)

EPCT-17. DEVELOPING EYA PHOSPHATASE INHIBITORS WITH ON-TARGET EFFECTS IN SHH-MEDULLOBLASTOMA
por: H. Hwang, Grace, et al.
Publicado: (2021)

EMBR-33. YAP1 FUNCTION IN SHH MEDULLOBLASTOMA PROGRESSION AND IMMUNE EVASION
por: Abdelfattah, Nourhan, et al.
Publicado: (2021)

MEDB-48. Infant medulloblastoma - SHH subtype – with residual disease. To treat or not to treat
por: Dahl, Christine, et al.
Publicado: (2022)

MEDB-66. Investigating intra-tumoral heterogeneity of extrachromosomal DNA in SHH medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022)

Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
por: Zhang, Zhen-Yu, et al.
Publicado: (2014)

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
por: Kool, Marcel, et al.
Publicado: (2012)

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
Publicado: (2014)

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
Publicado: (2014)

Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model
por: Singh, Alok R, et al.
Publicado: (2014)

Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma
por: Landry, Alexander P., et al.
Publicado: (2021)

Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse
por: Guo, Duancheng, et al.
Publicado: (2021)

MBRS-06. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA
por: Natsumeda, Manabu, et al.
Publicado: (2020)

Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma
por: Westphal, Maximillian S., et al.
Publicado: (2021)

O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling
por: Chen, Liping, et al.
Publicado: (2022)

An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside
por: Zhu, Jingwen, et al.
Publicado: (2022)

Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma
por: Lukoseviciute, Monika, et al.
Publicado: (2023)

MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
por: Erker, Craig, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q4197i4kust8su260c6gd7bdg9